| GSK Pharma launches two more cancer drugs - Business Standard |
|
|
Business Standard Votrient (pazopanib hydrochloride tablets) is for treating advanced renal cell carcinoma (RCC), the most common type of kidney cancer. According to estimates, 8900 new cases of kidney cancer are reported every year in India and 5733 people suffering |